ETV3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.311400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.238600E-01
Normal-vs-Stage2
5.691000E-01
Normal-vs-Stage3
6.342000E-01
Normal-vs-Stage4
1.631850E-01
Stage1-vs-Stage2
9.262800E-01
Stage1-vs-Stage3
1.960600E-01
Stage1-vs-Stage4
2.151600E-01
Stage2-vs-Stage3
2.884400E-01
Stage2-vs-Stage4
1.979180E-01
Stage3-vs-Stage4
8.232000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.668000E-01
Normal-vs-AfricanAmerican
3.491600E-01
Normal-vs-Asian
6.065600E-01
Caucasian-vs-AfricanAmerican
5.227600E-01
Caucasian-vs-Asian
6.294200E-01
AfricanAmerican-vs-Asian
8.492400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.089800E-01
Normal-vs-Female
6.571200E-01
Male-vs-Female
8.553200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.636000E-01
Normal-vs-Age(41-60Yrs)
4.172600E-01
Normal-vs-Age(61-80Yrs)
7.274800E-01
Normal-vs-Age(81-100Yrs)
6.798400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.899600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.986400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.727600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.342300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.880300E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.159000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.520400E-01
Normal-vs-Daily Drinker
9.035600E-01
Normal-vs-Weekly Drinker
7.362200E-01
Normal-vs-Occasional Drinker
3.786400E-01
Normal-vs-Social Drinker
7.151200E-01
Non Drinker-vs-Daily Drinker
3.530400E-01
Non Drinker-vs-Weekly Drinker
9.800400E-01
Non Drinker-vs-Occasional Drinker
1.370980E-01
Non Drinker-vs-Social Drinker
9.282400E-01
Daily Drinker-vs-Weekly Drinker
4.100600E-01
Daily Drinker-vs-Occasional Drinker
3.498000E-02
Daily Drinker-vs-Social Drinker
3.700000E-01
Weekly Drinker-vs-Occasional Drinker
2.345200E-01
Weekly Drinker-vs-Social Drinker
9.546200E-01
Occasional Drinker-vs-Social Drinker
2.453000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.662800E-01
Normal-vs-Grade 2
7.911600E-02
Normal-vs-Grade 3
6.918100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.888100E-02
Grade 1-vs-Grade 3
4.195800E-02
Grade 1-vs-Grade 4
2.662800E-01
Grade 2-vs-Grade 3
9.770200E-01
Grade 2-vs-Grade 4
7.911600E-02
Grade 3-vs-Grade 4
6.918100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.021600E-01
Normal-vs-NonDiabetic
7.625000E-01
Diabetic-vs-NonDiabetic
6.666400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.456400E-01
Normal-vs-NoPancreatitis
7.081800E-01
Pancreatitis-vs-NoPancreatitis
8.391000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.393600E-01
Normal-vs-N1
5.811400E-01
N0-vs-N1
5.024800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.795000E-01
Normal-vs-TP53-NonMutant
7.509400E-01
TP53-Mutant-vs-TP53-NonMutant
1.468970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
